Literature DB >> 18258377

In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma.

Quynh-Thu Le1, Albert Koong, Yee Yie Lieskovsky, Balasubramanian Narasimhan, Edward Graves, Harlan Pinto, J Martin Brown, Daniel Spielman.   

Abstract

PURPOSE: To investigate in vivo(1)H magnetic resonance spectroscopy imaging of lactate for assessing tumor hypoxia in head and neck cancers and to determine its utility in predicting the response and outcomes. METHODS AND MATERIALS: Volume-localized lactate-edited (1)H magnetic resonance spectroscopy at 1.5 T was performed in vivo on involved neck nodes and control subcutaneous tissues in 36 patients with Stage IV head and neck cancer. The signal intensities (SIs) of lactate, choline, and creatine and the choline/creatine ratio were measured. The tumor partial pressure of oxygen (pO(2)) was obtained in the same lymph node before MRS. Patients were treated with either two cycles of induction chemotherapy (tirapazamine, cisplatin, 5-fluorouracil) followed by simultaneous chemoradiotherapy or the same regimen without tirapazamine. The lactate SI and the choline/creatine ratio correlated with the tumor pO(2), nodal response, and locoregional control.
RESULTS: The lactate SI was greater for the involved nodes (median, 0.25) than for the subcutaneous tissue (median, 0.04; p = 0.07). No significant correlation was found between the lactate SI and tumor pO(2) (mean, 0.46 +/- 0.10 for hypoxic nodes [pO(2) < or =10 mm Hg, n = 15] vs. 0.36 +/- 0.07 for nonhypoxic nodes [pO(2) >10 mm Hg, n = 21], p = 0.44). A significant correlation was found between the choline/creatine ratios and tumor pO(2) (mean, 2.74 +/- 0.34 for hypoxic nodes vs. 1.78 +/- 0.31 for nonhypoxic nodes, p = 0.02). No correlation was found between the lactate SI and the complete nodal response (p = 0.52) or locoregional control rates.
CONCLUSIONS: The lactate SI did not correlate with tumor pO(2), treatment response, or locoregional control. Additional research is needed to refine this technique.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258377      PMCID: PMC2601688          DOI: 10.1016/j.ijrobp.2007.11.030

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  23 in total

1.  Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas.

Authors:  T Tamiya; K Kinoshita; Y Ono; K Matsumoto; T Furuta; T Ohmoto
Journal:  Neuroradiology       Date:  2000-05       Impact factor: 2.804

2.  Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer.

Authors:  D M Brizel; T Schroeder; R L Scher; S Walenta; R W Clough; M W Dewhirst; W Mueller-Klieser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

3.  In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.

Authors:  J M Star-Lack; E Adalsteinsson; M F Adam; D J Terris; H A Pinto; J M Brown; D M Spielman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

4.  1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas.

Authors:  Rafal Tarnawski; Maria Sokol; Piotr Pieniazek; Boguslaw Maciejewski; Jerzy Walecki; Leszek Miszczyk; Teresa Krupska
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-04-01       Impact factor: 7.038

5.  Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer.

Authors:  V Rudat; B Vanselow; P Wollensack; C Bettscheider; S Osman-Ahmet; M J Eble; A Dietz
Journal:  Radiother Oncol       Date:  2000-10       Impact factor: 6.280

Review 6.  Clinical applications of proton MR spectroscopy in oncology.

Authors:  Lester Kwock; J Keith Smith; Mauricio Castillo; Matthew G Ewend; Sharon Cush; Thomas Hensing; Mahesh Varia; David Morris; Thomas W Bouldin
Journal:  Technol Cancer Res Treat       Date:  2002-02

Review 7.  Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.

Authors:  Quynh-Thu Le; Amato J Giaccia
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

8.  Oxygen tension measurements of head and neck cancers.

Authors:  D J Terris; E P Dunphy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-03

9.  Correlation of high lactate levels in human cervical cancer with incidence of metastasis.

Authors:  G Schwickert; S Walenta; K Sundfør; E K Rofstad; W Mueller-Klieser
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

10.  Lactate, choline, and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer.

Authors:  Hajime Yokota; Jianfei Guo; Munetaka Matoba; Kotaro Higashi; Hisao Tonami; Yosinobu Nagao
Journal:  J Magn Reson Imaging       Date:  2007-05       Impact factor: 4.813

View more
  8 in total

1.  Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.

Authors:  Vlad C Sandulache; Yunyun Chen; Heath D Skinner; Tongtong Lu; Lei Feng; Laurence E Court; Jeffrey N Myers; Raymond E Meyn; Clifton D Fuller; James A Bankson; Stephen Y Lai
Journal:  Mol Cancer Ther       Date:  2015-09-16       Impact factor: 6.261

2.  Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.

Authors:  Jacobus F A Jansen; Heiko Schöder; Nancy Y Lee; Hilda E Stambuk; Ya Wang; Matthew G Fury; Snehal G Patel; David G Pfister; Jatin P Shah; Jason A Koutcher; Amita Shukla-Dave
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

Review 3.  Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.

Authors:  Kelly M Kennedy; Mark W Dewhirst
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

4.  Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy.

Authors:  Ann D King; David K W Yeung; Kwok-Hung Yu; Frankie K F Mo; Chen-Wen Hu; Kunwar S Bhatia; Gary M K Tse; Alexander C Vlantis; Jeffrey K T Wong; Anil T Ahuja
Journal:  Eur Radiol       Date:  2009-08-05       Impact factor: 5.315

5.  Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.

Authors:  M Beloueche-Babari; C Box; V Arunan; H G Parkes; M Valenti; A De Haven Brandon; L E Jackson; S A Eccles; M O Leach
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter.

Authors:  Geoffrey S Payne; Nandita M deSouza; Christina Messiou; Martin O Leach
Journal:  NMR Biomed       Date:  2015-04       Impact factor: 4.044

7.  Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism.

Authors:  Wangie Yu; Yunyun Chen; Julien Dubrulle; Fabio Stossi; Vasanta Putluri; Arun Sreekumar; Nagireddy Putluri; Dodge Baluya; Stephen Y Lai; Vlad C Sandulache
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

8.  Validating a robust double-quantum-filtered (1) H MRS lactate measurement method in high-grade brain tumours.

Authors:  G S Payne; L M Harris; G S Cairns; C Messiou; N M deSouza; A Macdonald; F Saran; M O Leach
Journal:  NMR Biomed       Date:  2016-08-11       Impact factor: 4.044

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.